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In this issue of Immunity, Na et al. (2012) show that the purging of central nervous system (CNS)-specificCD8+
T cell repertoire requires direct contact with antigen expressing oligodendrocytes and inflammation tips the
balance toward autoimmunity.Current concepts consider multiple scle-
rosis (MS) an autoimmune disease.
Indeed, the genetic control of disease
risk (risk genes are mostly related to
immune responses), histology of the
lesion (T cell, B cell, and macrophage
infiltrates), and good responses to immu-
nomodulatory therapies are all consistent
with the definition of autoimmunity. Fur-
ther support of the autoimmune concept
of MS comes from animal models of brain
autoimmunity. MS-like disease can be
readily induced in experimental animals
by immunological manipulation. Active
immunization against brain protein anti-
gens, transfer of brain-specific T cells, or
the overrepresentation of brain-specific
T cell receptors (TCRs) in transgenic
mice have produced disease replicating
MS with remarkable fidelity. But there
remains one fundamental dilemma:
whereas most of the available experi-
mental autoimmune encephalomyelitis
(EAE) models are driven by autoimmune
CD4+ ‘‘helper’’ T cells, in MS, the immune
infiltrates in active lesions are dominated
by CD8+ T cells, putative cytotoxic
‘‘killer’’ cells (Friese and Fugger, 2005).
These CD8+ T cells not only outnumber
local CD4+ T cells, but use antigen
receptor repertoires strongly suggestive
of local antigen-driven immune responses
(Junker et al., 2007).
This inconsistency obviously questions
the use of CD4+ T cell-mediated EAE as
a model of human MS and creates an
urgent need of complementary CD8+
T cell-mediated models, but this had
been notoriously difficult. Goverman
pioneered the field isolating myelin
basic protein (MBP)-specific T cells from
MBP-deficient mutant mice. The myelin-
specific CD8+ T cells, when transferred
at high numbers, confer clinical and
histological EAE in hosts, which are
conditioned by irradiation and cytokine8 Immunity 37, July 27, 2012 ª2012 Elsevierinfusion. However, transgenic mice with
brain-specific TCRs remain intact (Gover-
man, 2009).
CD8+ T cell-mediated autoimmunity in
the brain has been replicated elegantly
by surrogate autoimmune models. These
employ transgenic animals that express
foreign proteins in particular brain cells
and are considered by immune system
as self-antigens. These ‘‘neoantigens’’
can be confronted in situ with cognate
CD8+ T cells, either via cell transfers or
by introducing the specific CD8 TCR
transgene. One successful example is
the influenza virus hemagglutinin, HA,
which is recognized by a mouse CD8+
T cell clone. These cells attack brain
cells that express a HA-encoding trans-
gene, creating an inflammation mimicking
a ‘‘real’’ autoimmune disease (Saxena
et al., 2008).
In this issue of Immunity, Na et al. (2012)
adopted this strategy expressing oval-
bumin as a neoantigen in myelin-forming
oligodendrocytes (ODCs). The comple-
mentary CD8+ T cells used the TCR from
the OT-I clone, a classic paradigm recog-
nizing ovalbumin peptide SIINFEKL in
context of an MHC class I product,
H2Kb. This model led to two conflicting
observations. On the one hand, the inves-
tigators noted that double-transgenics
harboring ovalbumin in ODCs along with
large numbers of OT-I-like CD8+ T cells
spontaneously developed a devastating
EAE around postnatal day 14, much
earlier than in comparable CD4+ T cell
models of spontaneous EAE (Berer
et al., 2011). Unexpectedly, however,
attempts to produce EAE in adult oval-
bumin single-transgenic mice by active
immunization failed. Even the transfer of
massive doses of OT-I T cells mediated
disease in only few animals.
The group set out to resolve this
apparent inconsistency by investigatingInc.the cellular basis of CD8+ T cell-mediated
self-tolerance and its generation. The
resulting study (Na et al., 2012) now
makes an amazing story, one which
raises questions on present concepts of
CD8+ T cell-mediated self-tolerance in
the brain, as well as in other organs.
The central message from this work is
that self-reactive CD8+ T cells are purged
from the permissive repertoire at an early
stage of postnatal development and that
this purging is the consequence of
direct contacts of self-reactive CD8+
T cells with autoantigen producing oligo-
dendrocytes involving Fas/FasL-depen-
dent apoptosis (Figure 1). Autoimmune
CD8+ T cells released later from the
adult thymus are thought to be purged
successively via transient opening of the
dense blood-brain-barrier (BBB). In this
model, the role of the CNS target tissue
is ambivalent: in the resting state it purges
autoimmune T cells; however, activation
by local infection renders the tissue
vulnerable to T cell autoimmune attack.
This raises tantalizing questions.
Contact-dependent purging during early
postnatal development depends first of
all on the production of ovalbumin by
the developing ODCs and second on
increased permeability of the immature
BBB to circulating CD8+ T cells. Clearly,
the production of the ovalbumin neoanti-
gen at this early period is firmly docu-
mented by the present work. Also, the
relative leakiness of the postnatal
BBB to blood macromolecules can be
assumed, although this may not neces-
sarily imply an enhanced traffic of circu-
lating blood lymphocytes. With regard
to the mechanism of clonal purging,
the data strongly point to the Fas/FasL
apoptotic pathway activated by direct
contact between self-reactive CD8+
T cells and antigen-producing oligo-
dendrocyte targets. Contact-dependent
Figure 1. Contact of Brain-Specific CD8+ T Cells and Target
Oligodendrocyte in Self-Tolerance and Autoimmunity
Self-tolerance is achieved in early postnatal development (A), when unse-
lected CD8+ T cells percolate through the partly leaky blood-brain barrier
(BBB) into the brain tissue, where oligodendrocyte-autoreactive clones are
deleted from repertoire. In adults (B), the closed BBB holds back all CD8
T cells, whereas during episodes of peripheral inflammation (C), the BBB
opens and admits unselected CD8+ T cells to allow deletion of autoreactive
clones after contact with oligodendrocytes. Autoimmunity develops in post-
natal animals (D) in the presence of overwhelming proportions of autoimmune
clones (T cell receptor transgenicmice). In adults, priming of the brainmilieu by
local infection (E) allows autoreactive CD8+ T cells to attack the oligodendro-
cytes without being deleted.
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further corroborated by a
transplantation experiment.
Oligodendrocyte progenitor
cells engineered to make
ovalbumin were grafted ster-
eotactically into a small area
of the cerebellar white matter
of normal mice. This tiny
spot of ovalbumin production
was sufficient to allow purg-
ing specific CD8+ T cells
from the global peripheral
repertoire.
But how are self-reactive
T cells picked out of the entire
clonal repertoire? Does this
imply an invasion of the
tissue by virtually all circu-
lating CD8+ T cells with
specific deletion of self-reac-
tive clones? This would imply
massive T cell infiltrates,
which however have not
been reported. Alternatively,
do self-reactive T cells prefer-
entially invade the tissue?
In that latter case, it will be
interesting to search for the
location and nature of the
‘‘go-signal’’ discriminating
between self- and non-self-
reactive T cells.
The arguments support-
ing intra-CNS deletion of
brain-autoreactive T cells are
convincing, but they do not
completely rule out an alter-
native scenario, which would
move the arena of autoim-
mune purging out of the
CNS, most obviously into
CNS-draining cervical lymph
nodes. This would imply the
export of brain-derived anti-
gens into the peripheral
tissues. However, Na et al.
firmly excluded adoptive pre-sentation by microglia or other potential
APCs. Indeed, they were unable to detect
ovalbuminmRNAoutside theCNSanddid
not find ovalbumin protein on cells other
than oligodendrocytes. However, reloca-
tion of myelin proteins to the cervical
lymph nodes was directly shown in other
experimental setups (de Vos et al., 2002),
and there is good evidence that in a trans-
genic model of spontaneous CD4+ T cell-
mediated EAE, exported myelin autoanti-gen is required to actively recruit myelin-
specific B lymphocytes in these lymph no-
des (Berer et al., 2011). Furthermore,
adoptive presentation of myelin autoanti-
gen is a hallmark of classical CD4+ T cell-
mediated EAE. Oligodendrocytes are not
inducible to express major histocompati-
bility complex (MHC) class II determi-
nants, which are critically required for
autoantigen presentation to CD4+ T cells.
Hence, class II inducible local phagocytesImmunity 37, July 2and astrocytes must pick up
the autoantigen material and
processed it to a presentable
structure. The discrepancy
between the ovalbumin and
myelin autoimmune models
may lie in the nature of the
target autoantigens. Trans-
genic ovalbumin studied here
is a cytosolic protein, the
processing and presenting
of which may follow other
immunological rules than do
membrane-associatedmyelin
proteins (such as MBP, PLP,
and MOG).
Another intriguing question
concerns the immune reper-
toire formed later during adult
life. The adult thymus contin-
uously produces and releases
CD8+ T cells, presumably
self-reactive clones included.
How are these deleted? The
authors speculate that these
latecomers could be removed
by successive episodes of
peripheral infections that
would open the BBB tran-
siently, thus allowing tempo-
rary access to purging oligo-
dendrocytes (Figure 1). This
mechanism, which invites
further experimentation, links
self-tolerance and autoim-
munity to innate immune
responses activated by mi-
crobial infection. It assigns
a beneficial, tolerogenic
effect to peripheral infection.
How might autoimmunity in
the CNS happen if OT-I
T cells were transferred into
OVA transgenic adult mice at
a time following develop-
mental closure of the blood
brain barrier? The investiga-
tors showed that tolerancecould be broken by infection of CNS tissue
by Listeria expressing the target autoanti-
gen ovalbumin. Small doses of Ova-Liste-
ria injected into the brainwere sufficient for
luring infusedOT-I T cells into the secluded
CNS tissues. There they find an altered
milieu, with oligodendrocytes vulnerable
to the autoimmune T cells (Figure 1). In
this scenario, the OT-I cells are no longer
deleted by the ODCs but rather activated
and cytotoxic.7, 2012 ª2012 Elsevier Inc. 9
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reveal the ambiguous, Janus-headed
nature of infection in CD8+ T cell-medi-
ated brain autoimmunity. On the one
hand, (mild) peripheral infection seems
to be required for maintaining purg-
ing of autoimmune CD8+ T cells from
the immune repertoire, while, on the
other hand, local infection may condition
CNS tissue to be attacked by these
T cells.
Time will tell how far these observations
will apply to the pathogenesis of MS. Do
infectious episodes impinge on T cell-
mediated self-tolerance on the one hand
and trigger disease bouts on the other?
Could the commensal gut flora have10 Immunity 37, July 27, 2012 ª2012 Elseviea role in these discrepant aspects of auto-
immunity? Before reaching conclusive
answers, we will have to learn whether
the CD8+ T cells dominating the active
MS lesions are indeed pathogenic effec-
tors or whether they act as regulators
of another pathogenic mechanism. The
CD8 question will be vexing for some
time to come.REFERENCES
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The mechanisms of how commensal bacteria impact systemic immunity are unclear. In this issue of
Immunity, Abt et al. (2012) and Ganal et al. (2012) demonstrate that microbiota poise macrophages for
induction of the type I interferon pathway after virus infection.Commensal bacteria facilitate multiple
aspects of intestinal homeostasis. In
addition to promoting structural and
metabolic functions, microbiota stimulate
the development of lymphoid follicles, IgA
production, antimicrobial proteins, and
accumulation of intraepithelial lympho-
cytes (Honda and Littman, 2012). Thus,
microbiota help to protect their host
from intestinal pathogens. Two studies in
this issue now demonstrate a crucial role
for commensal bacteria in controlling
systemic antiviral immunity. Both groups
discovered that the ability of phagocytic
cells to rapidly produce type I interferons
(IFNs) after virus infection requires a
conditioning phase of tonic signaling
through the type I IFN receptor (IFN-R),
and intestinal microbes were providing
this signal in the steady state. These
findings reveal a previously unknownpathway in which commensal organisms
augment macrophage responsiveness to
viruses by modulating their threshold of
activation.
Antiviral immune defense is coordi-
nated by dendritic cells (DCs) and natural
killer (NK) cells. In peripheral tissues,
DCs detect viral nucleic acids, resulting
in their migration to lymph nodes and
production of IFNs, which have broad
immunological effects (Gonza´lez-Navajas
et al., 2012). Autocrine signaling of type I
IFNs on DCs increases their expression
of antigen presenting and costimulatory
molecules, leading to CD8+ T cell clonal
expansion and effector differentiation.
Activated DCs also prime NK cell function
by producing cytokines involved in their
survival (IL-15), lytic activity (type I IFN),
and IFN-g production (IL-12). The direct
action of type I IFNs on CD8+ T cellspromotes their cytotoxic function against
infected cells in the periphery, which
present viral antigens on MHC class I. In
contrast, the ability of NK cells to sense
and lyse infected cells is controlled by
a complex set of activating and inhibitory
receptors. The overall effects of type I
IFNs on distinct cell types are mediated
by the binding of IRF family transcription
factors to hundreds of gene promoters
containing IFN-stimulated response
elements (ISREs). Thus, the regulation of
type I IFN activity is central to antiviral
host defense.
To study the role of commensal bac-
teria in systemic antiviral immunity, the
authors analyzed germ-free (GF) mice
(Ganal et al., 2012), or conventional mice
placed on water containing broad-
spectrum antibiotics (ABX; Abt et al.,
2012). In each of these cases, the absence
